Mononuclear myeloid cells can shape neutrophils in brain tumors

Sven Brandau1

  • 1Research Division, Department of Otorhinolaryngology, Head & Neck Surgery, University Hospital Essen, Essen, Germany; German Cancer Consortium, partner site Essen-Düsseldorf, Essen, Germany.

Trends in Immunology
|January 24, 2024
PubMed

Insights

Intratumoral neutrophils often signal poor cancer prognosis. A new study reveals a specific niche within brain tumors where myeloid cells activate these neutrophils, offering new insights into tumor-immune interactions.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • High intratumoral neutrophil frequency correlates with poor prognosis in many solid cancers.
  • Neutrophils are key immune cells implicated in cancer progression and patient outcomes.

Purpose of the Study:

  • To investigate the mechanisms of neutrophil activation within the tumor microenvironment.
  • To identify specific cellular interactions driving neutrophil responses in brain tumors.

Main Methods:

  • Analysis of the tumor microenvironment in brain tumors.
  • Identification of cellular players and signaling pathways involved in neutrophil activation.

Main Results:

  • Discovery of an intratumoral niche facilitating neutrophil activation.
  • Identification of mononuclear myeloid cells as drivers of proinflammatory neutrophil responses.

Conclusions:

  • Mononuclear myeloid cells play a critical role in modulating neutrophil activity within brain tumors.
  • Understanding this niche provides new therapeutic targets for improving cancer prognosis.